Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Anticoagulant Reversal Drugs Market Size study, by Drug Class (Prothrombin Complex Concentrates, Coagulation Factors, Monoclonal Antibodies, Phytonadione and Others), and Regional Forecasts 2020-2026

  • BIZ3834171
  • 200 Pages
  • April 2020
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Anticoagulant Reversal Drugs Market is valued approximately at USD 811.56 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 15.6% over the forecast period 2019-2026. Anticoagulant drugs are medicines that has application in protection from blood clotting, used to reverse or balance bleeding. It is also helpful in prevention of risk related to the anticoagulants that arises due to the overdose of an anticoagulant therapy or unplanned surgery. It also prevents from serious conditions such as strokes and heart attacks to the individual suffering from blood clots. The anticoagulant reversal drugs have commendable application in treatment and diagnosis of cardiovascular disease due to its advent benefits of removing and dissolving blood clots. Therefore, increasing prevalence of cardiovascular disease across the globe is attributed to the growth of market over the forecast years. For instance: As per the World Health Organization, Cardiovascular diseases are estimated as the primary reason of death due to disease across the globe which accounts for over 17.9 million, 31% of worldwide death each year due to cardiovascular disease. It is estimated that more than 75% of deaths occurred through cardiovascular disease is emerged in low and middle-income countries and over 85% of deaths are taking place due to sever heart attacks and strokes. Moreover, rise in geriatric population and rapid growth of problems regarding blood clots in such population gave exponential rise in the demand of anticoagulant reversal drugs across the globe. However, the high cost of patented drugs would deter the growth of market in the emerging economies over the forecast years.

The regional analysis of global Anticoagulant Reversal Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rapid growth in cases of cardiovascular disease in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as presence of large geriatric population in the emerging economies of the region would create lucrative growth prospects for the Anticoagulant Reversal Drugs market across Asia-Pacific region.

Major market player included in this report are:

Portola Pharmaceuticals Inc

Boehringer Ingelheim GmbH

CSL Behring Limited

Pfizer Inc

Octapharma AG

Bausch Health Companies Inc

Amneal Pharmaceuticals Inc

Fresenius Kabi AG

Perosphere Pharmaceuticals Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Prothrombin Complex Concentrates

Coagulation Factors

Monoclonal Antibodies

Phytonadione

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Anticoagulant Reversal Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)

1.2.1. Anticoagulant Reversal Drugs Market, by Region, 2018-2026 (USD Million)

1.2.2. Anticoagulant Reversal Drugs Market, by Drug Class, 2018-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Anticoagulant Reversal Drugs Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Anticoagulant Reversal Drugs Market Dynamics

3.1. Anticoagulant Reversal Drugs Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Anticoagulant Reversal Drugs Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Anticoagulant Reversal Drugs Market, by Drug Class

5.1. Market Snapshot

5.2. Global Anticoagulant Reversal Drugs Market by Drug Class, Performance - Potential Analysis

5.3. Global Anticoagulant Reversal Drugs Market Estimates & Forecasts by Drug Class 2016-2026 (USD Million)

5.4. Anticoagulant Reversal Drugs Market, Sub Segment Analysis

5.4.1. Prothrombin Complex Concentrates

5.4.2. Coagulation Factors

5.4.3. Monoclonal Antibodies

5.4.4. Phytonadione

5.4.5. Others

Chapter 6. Global Anticoagulant Reversal Drugs Market, Regional Analysis

6.1. Anticoagulant Reversal Drugs Market, Regional Market Snapshot

6.2. North America Anticoagulant Reversal Drugs Market

6.2.1. U.S. Anticoagulant Reversal Drugs Market

6.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026

6.2.2. Canada Anticoagulant Reversal Drugs Market

6.3. Europe Anticoagulant Reversal Drugs Market Snapshot

6.3.1. U.K. Anticoagulant Reversal Drugs Market

6.3.2. Germany Anticoagulant Reversal Drugs Market

6.3.3. Rest of Europe Anticoagulant Reversal Drugs Market

6.4. Asia-Pacific Anticoagulant Reversal Drugs Market Snapshot

6.4.1. China Anticoagulant Reversal Drugs Market

6.4.2. India Anticoagulant Reversal Drugs Market

6.4.3. Japan Anticoagulant Reversal Drugs Market

6.4.4. Rest of Asia Pacific Anticoagulant Reversal Drugs Market

6.5. Latin America Anticoagulant Reversal Drugs Market Snapshot

6.5.1. Brazil Anticoagulant Reversal Drugs Market

6.5.2. Mexico Anticoagulant Reversal Drugs Market

6.6. Rest of The World Anticoagulant Reversal Drugs Market

Chapter 7. Competitive Intelligence

7.1. Top Market Strategies

7.2. Company Profiles

7.2.1. Portola Pharmaceuticals, Inc.

7.2.1.1. Key Information

7.2.1.2. Overview

7.2.1.3. Financial (Subject to Data Availability)

7.2.1.4. Product Summary

7.2.1.5. Recent Developments

7.2.2. Boehringer Ingelheim GmbH

7.2.3. CSL Behring Limited

7.2.4. Pfizer Inc

7.2.5. Octapharma AG

7.2.6. Bausch Health Companies, Inc.

7.2.7. Amneal Pharmaceuticals Inc

7.2.8. Fresenius Kabi AG

7.2.9. Perosphere Pharmaceuticals Inc

Chapter 8. Research Process

8.1. Research Process

8.1.1. Data Mining

8.1.2. Analysis

8.1.3. Market Estimation

8.1.4. Validation

8.1.5. Publishing

8.2. Research Attributes

8.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET

TABLE 3. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD MILLION)

TABLE 8. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 9. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 10. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 11. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 20. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 21. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 23. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 24. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 26. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 27. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 29. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 30. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 32. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 33. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 34. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 35. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 36. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 37. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 39. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 40. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 43. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 46. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 47. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 49. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 51. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 52. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 54. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 55. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research